1. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. Issue 2 (February 2020) Authors: Lonial, Sagar; Lee, Hans C; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Lendvai, Nikoletta; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Karlin, Lionel; Libby, Edward; Arnulf, Bertrand; Facon, Thierry; Hulin, Cyrille; Kortüm, K Mart... Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. Issue 10192 (6th July 2019) Authors: Moreau, Philippe; Attal, Michel; Hulin, Cyrille; Arnulf, Bertrand; Belhadj, Karim; Benboubker, Lotfi; Béné, Marie C; Broijl, Annemiek; Caillon, Hélène; Caillot, Denis; Corre, Jill; Delforge, Michel; Dejoie, Thomas; Doyen, Chantal; Facon, Thierry; Sonntag, Cécile; Fontan, Jean; Garderet, Laurent; ... Journal: Lancet Issue: Volume 394:Issue 10192(2019) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. (3rd February 2020) Authors: Boccon‐Gibod, Clémentine; Talbot, Alexis; Le Bras, Fabien; Frenzel, Laurent; Royer, Bruno; Harel, Stephanie; Lombion, Naelle; Belhadj, Karim; Cuccuini, Wendy; Arnulf, Bertrand Journal: British journal of haematology Issue: Volume 189:Number 3(2020) Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment. Issue 3 (21st June 2022) Authors: Abecassis, Audrey; Roders, Nathalie; Fayon, Maxime; Choisy, Caroline; Nelson, Elisabeth; Harel, Stephanie; Royer, Bruno; Villesuzanne, Camille; Talbot, Alexis; Garrick, David; Goodhardt, Michele; Fermand, Jean‐Paul; Burbridge, Mike; Arnulf, Bertrand; Bories, Jean‐Christophe Journal: EJHaem Issue: Volume 3:Issue 3(2022) Page Start: 970 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature. (15th December 2019) Authors: Elessa, Dikélélé; Talbot, Alexis; Lombion, Naëlle; Harel, Stéphanie; Galicier, Lionel; Veyradier, Agnès; Joly, Bérangère; Andreoli, Annalisa; Rigaudeau, Sophie; Azoulay, Élie; Coppo, Paul; Royer, Bruno; Arnulf, Bertrand Journal: British journal of haematology Issue: Volume 188:Number 2(2020) Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Diagnostic score of cardiac involvement in AL amyloidosis. (10th July 2019) Authors: Nicol, Martin; Baudet, Mathilde; Brun, Stephanie; Harel, Stephanie; Royer, Bruno; Vignon, Marguerite; Lairez, Olivier; Lavergne, David; Jaccard, Arnaud; Attias, David; Macron, Laurent; Gayat, Etienne; Cohen-Solal, Alain; Arnulf, Bertrand; Logeart, Damien Journal: European heart journal Issue: Volume 21:Number 5(2020) Page Start: 542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Exploratory analysis of intensified conditioning as first line treatment for patients with high risk multiple myeloma. Issue 4 (29th July 2020) Authors: Bommier, Côme; Talbot, Alexis; Harel, Stéphanie; Cuccuini, Wendy; Gérard, Laurence; Arnulf, Bertrand Journal: Hematological oncology Issue: Volume 38:Issue 4(2020) Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FC 114: Monoclonal Gammopathy in Kidney Transplanted Patients: Novel Insights into Long-Term Outcomes. (3rd May 2022) Authors: Meuleman, Marie-Sophie; Mouyabi, Steven; Gueguen, Juliette; Vicca, Stéphanie; Aubert, Olivier; Bienaimé, Frank; Arnulf, Bertrand; Anglicheau, Dany; Bridoux, Franck; Cohen, Camille Journal: Nephrology dialysis transplantation Issue: Volume 37(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial. Issue 3 (20th January 2021) Authors: Perrot, Aurore; Facon, Thierry; Plesner, Torben; Usmani, Saad Z.; Kumar, Shaji; Bahlis, Nizar J.; Hulin, Cyrille; Orlowski, Robert Z.; Nahi, Hareth; Mollee, Peter; Ramasamy, Karthik; Roussel, Murielle; Jaccard, Arnaud; Delforge, Michel; Karlin, Lionel; Arnulf, Bertrand; Chari, Ajai; He, Jianming;... Journal: Journal of clinical oncology Issue: Volume 39:Issue 3(2021) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma. Issue 6 (11th May 2020) Authors: Roussel, Murielle; Hebraud, Benjamin; Hulin, Cyrille; Perrot, Aurore; Caillot, Denis; Stoppa, Anne-Marie; Macro, Margaret; Escoffre, Martine; Arnulf, Bertrand; Belhadj, Karim; Karlin, Lionel; Garderet, Laurent; Facon, Thierry; Guo, Shien; Weng, Josh; Dhanasiri, Sujith; Leleu, Xavier; Moreau, Phil... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 6(2020) Page Start: 1323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗